EVELO BIOSCIENCES, INC.

EVLO NASDAQ
6.76
-0.18
-2.59%
Closed 16:00 08/22 EDT
Open
7.04
Prev Close
6.94
High
7.04
Low
6.74
Volume
11.43K
Avg Vol (3M)
41.82K
52 Week High
15.89
52 Week Low
4.897
% Turnover
0.04%
Market Cap
215.44M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers EVELO BIOSCIENCES, INC. EVLO stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Evelo Biosciences, Inc. is engaged in developing therapies designed to act on gut-body network. The Company develops monoclonal microbes that are orally-delivered compositions of specific strains of naturally occurring microbes derived from a single clone. Its principal product candidates include EDP1066, EDP1815, and EDP1503 that are in the pre-clinical development stage. EDP1066 and EDP1815 are monoclonal microbial product candidates that are developed to treat inflammatory diseases that include psoriasis, atopic dermatitis, rheumatoid arthritis, and ulcerative colitis. EDP1503 is the Company's product candidate developed under oncology portfolio to treat diseases, such as colorectal cancer, renal cell carcinoma, and melanoma among others.
MORE >

Recently

Name
Price
%Change